Magnesium and selenium belong to important bioelements. Magnesium is the second most abundant intracellular macroelement, which takes part in the metabolism of carbohydrates, nucleic acids, protein and lipids. Selenium is an essential microelement, whose deficit has been stated in many different pathological states. Much research on safe and effective selenium supplementation has been performed for the last fifty years but the results still remain unsatisfactory.
most abundant intracellular macroelement, which takes part in the metabolism of carbohydrates, nucleic acids, protein and lipids. Selenium is an essential microelement, whose deficit has been stated in many different pathological states. Much research on safe and effective selenium supplementation has been performed for the last fifty years but the results still remain unsatisfactory.
The aim of our study was to investigate the influence of inorganic sodium selenite Na 2 SeO 3 and two selenoorganic compounds synthetized at our chair on magnesium concentration in tissues of adolescent male Wistar rats. Inorganic selenite was administered as a water solution, whereas organic compounds: 4-(o-tolilo)-selenosemikarbazyd of 2-chlorobenzoic acid of a chain structure (ORG-C) and 3-(o-chlorobenzoylamino)-2-(o-tolylimino)-4--methyl-4-selenazoline of a ring structure (ORG-R) were suspended in emulsion (oil, arabic gum and water). Selenium compounds were given to rats at a dose of 5⋅10 -4 mg Se g -1 b.w. once a day for a period of 10 days. The control group was treated with saline. The administration was performed with use of a stomach tube.
In comparison to the control group, selenium supplementation caused decrease in magnesium concentration in kidney and lung tissues, but did not cause any changes in the brain and heart muscle. In the liver and spleen it was only ring selenazoline that affected magnesium concentration, increasing it in the liver and decreasing in the spleen. In the femoral muscle it was only the selenosemicarbazide chain that exerted the significant effect causing a decrease in Mg concentration vs the control group.
Selenium supplementation influences the tissue magnesium concentrations depending on tissue and structure of the supplement. Irrespective of the administered compound, it lowered magnesium in kidneys and lungs but caused no changes in the brain and heart muscle. In the liver, spleen and femoral muscle, alterations in the magnesium concentration were dependent on the provided supplement.
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WP£YW PODAWANIA ZWI¥ZKÓW SELENU NA TKANKOWE STÊ¯ENIE MAGNEZU U SZCZURÓW

Abstrakt
Magnez i selen nale¿¹ do biopierwiastków bardzo wa¿nych dla prawid³owego funkcjonowania organizmu. Magnez jest drugim co do ilooeci makropierwiastkiem wewn¹trzkomór-kowym, który odgrywa istotn¹ rolê w metabolizmie wêglowodanów, kwasów nukleinowych bia³ek i lipidów. Selen jest niezbêdnym mikroelementem, którego deficyt zosta³ stwierdzony w ró¿nych stanach patologicznych. Przez ostatnie 50 lat prowadzono rozleg³e badania nad skuteczn¹ i bezpieczn¹ suplementacj¹ tego pierwiastka, ale uzyskane wyniki nie s¹ do koñca satysfakcjonuj¹ce.
Celem pracy by³o zbadanie wp³ywu nieorganicznego selenianu(IV) sodu Na 2 SeO 3 i dwóch organicznych zwi¹zków selenu o ró¿nej budowie na stê¿enie magnezu w tkankach m³odych samców szczurów rasy Wistar. Nieorganiczny selenian(IV) sodu podawano w postaci wodnego roztworu, natomiast organiczne zwi¹zki selenu: 4-(o-tolilo)-selenosemikarbazyd kwasu 2-chlorobenzesowego (ORG-C, budowa ³añcuchowa) i 3-(2-chlorobenzoiloamino-)-2-(o-toliloimino-)-4-metylo-4-selenazolina (ORG-R, budowa pieroecieniowa) w formie emulsji z³o¿onej z oleju, gumy arabskiej i wody. Grupa kontrolna otrzymywa³a sól fizjologiczn¹. Zwi¹zki podawano sond¹ do¿o³¹dkowo w dawce 5⋅10 -4 mg Se g -1 m.c. 1 raz dziennie przez okres 10 dni.
W porównaniu z grup¹ kontroln¹ nieotrzymuj¹c¹ selenu, suplementacja zwi¹zkami Se wp³ynê³a na statystyczny spadek stê¿enia magnezu w tkankach nerki i p³uca, natomiast nie spowodowa³a ¿adnych zmian w tkance mózgu i miêoenia serca. W tkance w¹troby i oeledziony jedynie cykliczna selenazolina wp³ynê³a na stê¿enie magnezu -w w¹trobie zaobserwowano wzrost, a w oeledzionie spadek. W tkance miêoenia uda jedynie ³añcuchowy selenosemikarbazyd wywar³ istotny wp³yw, powoduj¹c obni¿enie stê¿enia Mg w stosunku do grupy kontrolnej.
Suplementacja selenu wp³ywa na tkankowe stê¿enie magnezu w sposób zale¿ny od rodzaju tkanki i struktury zastosowanego suplementu. Niezale¿nie od budowy podawanego zwi¹zku, zaobserwowano obni¿enie stê¿enia magnezu w tkance nerki i p³uca, natomiast nie zauwa¿ono ¿adnych zmian w mózgu i miêoeniu serca. W tkankach w¹troby, oeledziony i miêoenia uda zmiany stê¿enia magnezu by³y zale¿ne od rodzaju podawanego zwi¹zku.
INTRODUCTION
Magnesium is the second most abundant intracellular macroelement (TELCI et al. 2002) . It takes part in the metabolism of carbohydrates, nucleic acids, protein and lipids (BARBOSA et al. 2010) . Many disorders of functions in a human body can be connected with magnesium deficiency e.g.: disturbance of the cardiovascular system and homeostasis of other bioelements, muscle weakness as well as decreased parathyroid hormone secretion (SHO-BACK 2008 , ASSADI 2010 . Selenium belongs to essential trace bioelements and its deficiency in an organism may result in numerous severe diseases, for example a low selenium level has been found in cases of alimentary tract illnesses (SKELTON et al. 2006) , dermatic and nephrological disorders (INGEN-HOUSZ-ORO et al. 2004 , ZACHARA et al. 2004 ) and AIDS development after HIV-infection (RAYMAN 2000) . The question of selenium supplementation is rather complicated because of the narrow range between therapeutic and toxic doses (HAWKES et al. 2008) . Moreover, its bioavailability depends on the structure of a used supplement (BURK et al. 2006) . For the last fifty years extensive research on supplementation of selenium has been carried out (COMBS 2005 , ØEZANKA, SIGLER 2008 , SELAMOGLU TALAS et al. 2009 ), including both inorganic (sodium selenite or selenate) (IVANCIC, WEISS 2001 , UEZONO et al. 2006 ) and organic compounds (selenomethionine, selenocyanates, selenic acids of a chain structure as well as compounds of a cyclic form e.g. ebselen which has a benzisoselenazolone structure) (XIA et al. 2004 , BURKET et al. 2006 , CUI et al. 2008 . However, the problem of safe and efficient Se-supplementation still remains unsolved.
Two selenium organic compounds synthesized at our chair: 3-(2-chlorobenzoylamino)-2-(o-tolylimino)-4-methyl-selenazoline (MUSIK et al. 2009 ) possessing an ebselen-like, ring structure and 4-(o-tolyl)-selenosemicarbazide of 2-chlorobenzoic acid (MUSIK et al. 2002b ) of a chain structure were studied in regard of the possibility of their application as a selenium supplement. Taking into account the importance of magnesium for proper functions of a human organism, we investigated the effect of the oral administration of the above compounds on the Mg tissue concentrations in rats.
MATERIALS AND METHODS
The experiment was carried out on four groups of adolescent male Wistar rats (ten animals each): Group I -control treated with saline (n=10); Group II -treated with water solution of sodium selenite (Na 2 SeO 3 ), n=10; Group III -treated with 4-(o-tolyl)-selenosemicarbazide of 2-chlorobenzoic acid -compound ORG-C (n=10); Group IV -treated with 3-(2-chlorobenzoylamino)-2-(o-tolylimino)-4-methyl-4--selenazoline -compound ORG-R (n=10). The weight of the animals at the beginning of the study was within the range of 110-150 g. Organic compounds given to groups III and IV were suspended in emulsion composed of oil, arabic gum and water in the following proportions 2:1:1.5. Selenium compounds were given to rats at a dose of 5⋅10 -4 mg Se g -1 b.w. once a day for a period of 10 days. The administration was performed with use of a stomach tube. The body weight of animals was measured every day before Se administration. Rats had free access to standard feed LSM and drinking water.
After the experiment, the animals were sacrificed under pentothal narcosis and the tissues of their kidneys, liver, brain, spleen, femoral muscle, heart muscle and lungs were collected. Ten per cent (w/v) tissue homogenates were prepared in 0.1 mol dm -3 Tris -HCl buffer, pH = 7.4. Supernatants were obtained by centrifugation at 5000 x g for 30 min. The prepared material was stored at -18 o C.
Magnesium concentration in the supernatants was measured by the reaction with xylidyl blue (diagnostic set Liquick Cor-MG 60), using the colorimetric method. The wavelength was 520 nm. The assays were carried out with the help of a SPECORD M40 (Zeiss Jena) spectrophotometer.
Comparisons between the control and tested groups as well as between the selenium supplemented groups were made using c-Cochran-Cox test. The values were considered significant at p < 0.05.
The study was performed according to the statutory bioethical standards and approved by the Local Ethics Commission of the Medical University of Lublin, approval 65/AM/2004.
RESULTS AND DISCUSSION
The results obtained in the present experiment provided evidence to support interaction between magnesium and selenium. This effect was mainly observed in kidney and lung tissues. In comparison with the control group (without Se), selenium supplementation, regardless of its form, caused a decrease in the magnesium tissue concentration. In contrast, none of the Se supplement caused any changes in the brain and heart muscle. In the liver and spleen, it was only ring selenazoline that affected the magnesium concentration, casuing its increase in the liver and a decrease in the spleen. In the femoral muscle it was only chain selenosemicarbazide that exerted a significant effect vs the control group, causing a decrease in the Mg concentration.
Our comparison between the Se-treated groups showed that in some tissues the influence of selenium on Mg tissue concentration was dependent on its form. In the liver, ring selenazoline (group IV) increased Mg in comparison with the other groups receiving selenocompounds, significantly vs group III (given chain selenosemicarbazide). In the spleen, organic compounds diminished the Mg concentration in comparison with inorganic selenite and in group IV this effect was significant vs group III. In the femoral muscle, a distinct difference between organic compounds was displayed, namely chain selenosemicarbazide decreased Mg whereas ring selenazoline enhanced the level of this element, an effect which was evident vs group II (sodium selenite) and group III (selenosemicarbazide).
All the results of determinations are presented in Table 1 . 
In our previous experiment, we studied the effect of similar selenoorganic compounds on magnesium concentration in mice. The obtained results were the same in the brain, where no changes were observed. In the kidney and liver, inorganic selenite exerted the same effect causing significant decrease in the kidney and no alterations in the liver. A slight modification of the structure of an organic chain supplement (4-(o-tolyl)-selenosemicarbazide of 4-chlorobenzoic acid instead of 4-(o-tolyl)-selenosemicarbazide of 2-chlorobenzoic acid) resulted in distinct differences in its influence -in the kidney magnesium did not change significantly, whereas in the liver a decrease was observed. When the ring-structured supplement was applied, a more appreciable difference in the structure (3-(4-chlorobenzoylamino)-2--(o-tolylimino)-4-phenyl-4-selenazoline instead of 3-(2-chlorobenzoylamino)-2--(o-tolylimino)-4-methyl-4-selenazoline) altered its influence in the kidney, where no changes were noticed, and in the liver, where significant Mg depletion was determined. In the brain, the above modification of the supplement's structure did not change the effect of Se-supplementation (MUSIK et al. 2002a) .
Relationships between Mg and Se have already been reported (OSADA et al. 2002 , ERDAL et al. 2008 . Both elements play an important role in the diabetes therapy (MATEJ-BUTRYM, SCHABOWSKI 2008) and were reported to be effective agents for mercury toxicity (SHUKLA et al. 2007 ). Decrease in the serum magnesium and selenium was found in diabetic patients (KAMAL et al. 2009 ). In epileptic patients treated with valproic acid, increased serum selenium was observed but the magnesium concentration in serum was unaltered (HAMED et al. 2004) . Investigating changes in the magnesium level in tissue of animals subjected to selenium supplementation seems to be advisable because such determinations are possible only using an animal model. In horses administered a selenium-containing diet, no alterations of the plasma Mg were observed, irrespective of both Se-source (selenite or Se-yeast) and Se-dose (CALAMARI et al. 2010) . In rats receiving sodium selenite, enhanced fractional reabsorption of magnesium was displayed (SAKLY et al. 2003) . Inorganic selenium caused some increase in the Mg 2+ accumulation in K562 cells (JUN--YING, CUN-SHUAN 2009).
The effect of selenium can depend on other substances administered to experimental animals. In our study, Se did not alter Mg in the heart muscle of healthy rats. In rabbits administered daunorubicin, a significant decrease in the myocardial magnesium was accompanied by a slight increase in selenium (ŠIMUNEK et al. 2005) . Rats treated with dietary cadmium showed depressed Se and Mg in the liver (NOËL et al. 2004 ), although we did not observe any effect of the selenium treatment (sodium selenite or chain selenosemicarbazide groups) or an increase in the liver magnesium (ring selenazoline). Other factors can also influence the effect of Se-administration. In horses given selenium with vitamin E after exercise, a significant increase in serum Mg was observed, whereas before exercise no changes were obtained (YUR et al. 2008) . Sodium selenite caused only a slight enhancement of magnesium in lenses of rats exposed to cigarette smoke (DILSIZ et al. 1999) . Relationships between magnesium and selenium in an organism are also dependent on time. In rats fed a magnesium-deficient diet the kidney selenium was increased after 7 days, whereas in the heart such an effect was not observed until day 70 (JIMENEZ et al. 1997) . Similarly, in the present study, short-term administration of selenium compounds did not change the heart muscle magnesium.
CONCLUSIONS
1. Selenium supplementation influenced tissue magnesium concentrations depending on tissue and structure of the supplement.
2. Selenium supplementation, irrespective of an administered compound, caused magnesium depression in the kidney and lungs and no changes in the brain and heart muscle.
3. In the liver, spleen and femoral muscle, alterations of magnesium concentrations were was dependent on the provided supplement.
